期刊文献+

放射性核素^(99m)Tc-奥曲肽体内生物分布的研究 被引量:4

The study of biodistribution of ^(99m)Tc radiolabeled octreotide in rats and human
下载PDF
导出
摘要 目的:探讨99mTc-奥曲肽在生物体内与生长抑素受体结合的影像分布特性,为生长抑素受体显像提供实验依据。方法:利用薄层层析法计算99mTc-奥曲肽标记率与放化纯度。3只SD大鼠经静脉注射99mTc-奥曲肽后,在不同时间内显像并测定心血池放射性计数,计算奥曲肽血药浓度;3名志愿者静脉注射99mTc-奥曲肽后在不同时间内显像并观察人体内生长抑素受体分布。结果:99mTc-奥曲肽的放化纯度可以满足显像试验要求,静脉注射后在血中迅速进入器官组织,在肝脏中有较高浓度的聚集,主要经尿路排泄。结论:99mTc-奥曲肽在血液内清除速度快,主要在肝脏浓聚,并通过泌尿系统排泄,显像结果证明其具有很好的显像特性。 Aim: To evaluate the characteristic of receptor - binding of somatostain receptor imaging agent ^99mTc radiolabeled octreotide in vitro and provides the information for somatostain receptor imaging experiment. Methods: Label rate and purity were calculated with thin - layer chromatography. Radioactivity biodistribution assay was performed in 3 SD rats and clinical somatostatin receptor imaging was performed in three healthy volunteers after intravenous injection ^99mTc radiolabeled octreotide. Results: The radiochemical purity of ^99mTc radiolabeled octreotide was satisfied under the imaging requirement. ^99mTc radiolabeled octreotide removed from blood into organ and tissue and was high concentrated in the liver. The tracer excretes mostly from the urinary tract after injection. Conclusion: The blood radioactivity of ^99mTc radiolabeled octreotide decreased rapidly, the clear image indicates that the ^99mTc radiolabeled octreotide is a kind of nice imaging agent.
出处 《暨南大学学报(自然科学与医学版)》 CAS CSCD 北大核心 2006年第6期825-829,共5页 Journal of Jinan University(Natural Science & Medicine Edition)
基金 广东省重大科技专项(2003A3080501)
关键词 生长抑素 奥曲肽 SD大鼠 生物分布 somatostatin octreotide SD rat human biodistribution
  • 相关文献

参考文献7

二级参考文献67

  • 1王祖承,许东升,王继军,徐鹤定,陈三星,谢斌,曾政喜,杨献红,山田和男.σ受体[J].国外医学(精神病学分册),1994,21(1):1-4. 被引量:4
  • 2Boerman OC, Oyen WJG, Corstens FHM. Radio-labeled receptor binding peptides: a new class of radiopharmaceutical[J]. Semin Nucl Med, 2000, 30: 195-208.
  • 3Meko JB, Doherty GM, Siegel BA, et al. Evaluation of somatostatin receptor scintigraphy for detecting neuroendocrine tumors[J]. Surgery, 1996, 120: 975-984.
  • 4Slooter GD, Mearadji A, Breeman WAP, et al. Somatostatin receptor imaging, therapy and new strategies inpatients, with neuroendocrine tumors[J]. Brit J Surg, 2001,88: 31-40.
  • 5Warner RRP, O'Dorisio TM. Radiolabeled peptides in diagnosis and tumor imaging: clinical overview[J]. Semin Nucl Med, 2002, 32: 79-93.
  • 6Merrell RC. Octreotide scintigrapy[J]. Ann Surg, 1996,264: 117-118.
  • 7Papotti M, Kumar U, Volante M, et al. Immunohisto-chemical detection of somatostatin types 1-5 in medullary carcinoma of the thyroid [J]. Clin Endocrinol, 2001,54: 641-649.
  • 8Menda Y, Kahn D. Somatostatin receptor imaging of nonsmall cell lung cancer with 99m Tc depreotide[J]. Semin Nucl Med, 2002, 32: 92-96.
  • 9van de Wiele C, van Belle S, Sieghers G, et al. Receptor imaging in breast carcinoma: future prospects [J]. Eur J Nucl Med, 2001, 28:675-679.
  • 10Virgolini I, Traub T, Leimer M, et al. New radiopharmaceuticals for receptor scintigraphy and radionuclide therapy[J]. Quart J Nucl Med, 2000, 14: 50-58.

共引文献40

同被引文献39

  • 1段炼,李险峰,陆克义,张承刚,胡光,刘建中,李思进.^(99)Tc^m-奥曲肽眼眶显像在甲状腺相关眼病中的临床应用[J].中华眼科杂志,2006(12):1068-1072. 被引量:18
  • 2Hai-linLIU LiHUO LeiWANG.Octreotide inhibits proliferation and induces apoptosis of hepatocellular carcinoma cells[J].Acta Pharmacologica Sinica,2004,25(10):1380-1386. 被引量:15
  • 3刘燕强,辛天蓉,任自立.生长抑素及其受体[J].生理科学进展,2005,36(1):86-92. 被引量:19
  • 4张骏,姒健敏,梅彦,李勇,崔盈,王凡,贾宾.生长抑素受体介导^(90)Y-DOTA-Octreotide靶向抗肿瘤效应初探[J].实用肿瘤学杂志,2006,20(3):196-198. 被引量:1
  • 5Raghu G, Collard HR, Egan J J, et al. An official ATS/ERS/JRS/ ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med, 2011, 183(6): 788-824.
  • 6Jin S, Wang G, He B, et al. Gallium-67 scanning for detection of alveolitis in idiopathic pulmonary fibrosis and sarcoidosis. Chin Med J (Engl), 1996, 109(7): 519-521.
  • 7Mura M, Belmonte G, Fanti S, et al. Inflammatory activity is still present in the advanced stages of idiopathic pulmonary fibrosis. Respirology, 2005, 10(5): 609-614.
  • 8Hofland L J, Lamberts SW, van Hagen PM, et al. Crucial role for somatostatin receptor subtype 2 in determining the uptake of [11:In- DTPA-D-Phel]octreotide in somatostatin receptor-positive organs. J Nucl Med, 2003, 44(8): 1315-1321.
  • 9Lebtahi R, Moreau S, Marchand-Adam S, et al. Increased uptake of Htln-octreotide in idiopathic pulmonary fibrosis. J Nucl Med, 2006, 47(8): 1281-1287.
  • 10Pasquali D, Yassallo P, Esposito D, et al. Somatostatin receptor gene expression and inhibitory effects of octreotide on primary cultures of orbital fibroblasts from Graves' ophthalmopathy. J Mol Endocrinol, 2000, 25(1): 63-71.

引证文献4

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部